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Summal'y 
The contribution of autoimmunity in the genesis of chronic Chagas' heart pathology is not 
dear. In the present study, we show that: (a) BALB/c mice chronically infected with Trypanosoma 
cruzi reject syngeneic newborn hearts;  (b) in vivo treatment with anti-CD4 but not anti-CD8 
monodonal antibodies  (mAbs) abrogates rejection;  (c) CD4 + T calls from chronically infected 
mice proliferate in vitro to syngeneic myocardium antigens and induce heart graft destruction 
when injected in situ; (d) anti-CD4 treatment of chronically infected mice establishes long-term 
tolerance to syngeneic heart grafts;  and (e) the state of tolerance is related to in vitro and in 
vivo unresponsiveness  of the CD4 + T  cells. These findings  allow us  to  suggest  that  auto- 
immunity is the major mechanism implicated in the rejection of syngeneic heart tissues grafted 
into the pinna of the ear of mice chronically infected with T. cruzi.  The similarity of the lesions 
to those found in humans suggests that autoimmunity is involved in the pathogenesis of chagasic 
cardiomyopathy in humans. Moreover, this could imply therapeutic strategies by reestablishing 
long-term tissue-specific tolerance with anti-CD4 mAb treatment, mediating anergy, or deleting 
the responder  CD4 + T  cells to heart tissue antigens. 
C 
hagas' disease (American trypanosomiasis) is caused by 
transmission  of the protozoan Trypanosoma cruzi by a 
Triatoma bug. It is one of the leading causes of death in many 
countries of Latin America. The disease is characterized by 
three phases: acute, indeterminate, and chronic (1). The heart 
is the most severely and frequently affected organ. The de- 
gree of the cardiac involvement during the acute phase varies 
from mild to severe. The acute heart disease, which courses 
with parasitemia, is characterized histopathologically by foci 
of myocytolytic necrosis  and  an  impressive  mononudear 
inflammatory infiltrate directly related to tissular parasitism. 
The indeterminate phase is usually of long duration (up to 
10-30 yr) and is characterized by the absence of histopatho- 
logical lesions. Progression from the acute to chronic form 
of Chagas' disease coincides with clearance of parasites from 
blood stream and tissues. In the chronic phase variable degrees 
of cardiac hypertrophy and dilatation occur with or without 
thinning of the apical region (apical aneurism). Foci of myo- 
cardial necrosis and degeneration are present with an inflam- 
matory infiltrate predominantly composed of mononuclear 
cells and interstitial  fibrosis. Myofibers containing parasites 
are rarely observed. 
The participation  of autoimmune mechanisms in the gen- 
esis of the chronic myocarditis of Chagas' disease has been 
suggested and is still a controversial matter (2). Organ-specific 
autoimmunity is often related to the outcome of many para- 
sitic infections caused by virus, bacteria, and parasites (3-5). 
Thus, it would be of importance to find out how infection 
triggers autoimmunity and how the resultant autoimmunity 
contributes to the disease. This would improve therapeutical 
tools, thus contributing to the better understanding of the 
breaking of tissue-specific tolerance. 
The present  study was undertaken to investigate the au- 
toreactivity against syngeneic heart tissue in vivo by grafting 
newborn hearts into the pinna of the ear of mice chronically 
infected with T. cruzi. The results demonstrate that syngeneic 
heart tissues once grafted in normal recipients are accepted, 
while they are invariably rejected in mice chronically infected 
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T  lymphocytes and a state of tolerance can be reestablished 
by in vivo treatment of chronically infected mice with anti- 
CD4  mAbs before transplantation. 
Materials and Methods 
Mice.  BALB/c and C57BL/6 mice were bred and maintained 
under standard conditions in the animal colony at the Department 
of Immunology, University of S~o Paulo, Ribeitao Preto, Brazil. 
Parasites.  The Y  and the Colombian strains  of T. cruzi were 
used. Blood-derived trypomastigote forms were used in all experi- 
ments. Mice were infected subcutaneously with 103 parasites. The 
PF strain is nonpathogenic, noninfective, and has been shown to 
protect mice challenged with virulent T. cmzi strains (6). The PF 
strain is essentially represented by epimastigote forms and is main- 
tained in vitro in Warren's medium. In all experiments in which 
this strain was used, 2  x  107 parasites/animal/wk were injected 
during four consecutive weeks. 
Chronic Infection.  Mice infected with the Y strain of T. cmzi 
were obtained by selecting those animals that survived the acute 
phase.  However,  mice  infected with  the  Colombian  strain  of 
T. cruzi had to be treated during the acute infection with n-benzyl- 
2-nitro-l-amidazohcetamide (Rochagan, Roche Lab., Brazil), orally 
administered, in a dose of 100 mg/kg/d during 10 d, beginning 
on the 10th day after infection. 5-6 mo after challenge,  mice were 
considered in the chronic phase,  with no parasites  in the blood. 
Control mice were injected with saline instead of the PF, Y, and 
Colombian strains  of T  cruzi. 
Heart Transplantation Technique  We have modified the method 
originally described by Fulmer et al. (7). A full description appears 
dsewhere  (8).  Briefly,  newborn  mice  were  anesthesized  by 
hypothermia, and the heart was immediately excised, rinsed in cold 
sterile  saline (pH 7.2), and implanted into the dorsal base of the 
pinna of the ear. The implant was subcutaneous, and the surgical 
incision was gently dosed with the aid of forceps. In the present 
study grafts were sex matched, usually using male recipients.  In 
addition, in many experiments a given recipient had one graft in 
each ear, a procedure that allowed us to have in the same animal 
a control and an experimental heart transplant. The majority of 
grafts in normal syngeneic mice start to present contractile activity 
after 7-10 d posttransplantation. Rejection was defined macroscop- 
ically as the disappearance of the grafted tissue. This corresponded 
microscopically to perivascular, interstitial,  and perimyocytic mixed 
inflammatory infiltrate (lymphomononuclear ceils _+ neutrophils) 
with myocyte necrosis. 
Monoclonal  Antibodies.  Anti-L3T4  (GK1.5)  (9),  anti-Lyt-2 
(53.6.75) (10), and anti-Thy-l.2 (HO13.4 from American Type Cul- 
ture Collection, R_ockville,  MD) mAbs were obtained in the form 
of ascitic fluid. Gamma globulin fraction of the ascitic fluid was 
semi-purified by precipitation at 50% saturation with ammonium 
sulfate  and used for in vivo administration. 
In Vivo T  Cell Depletion.  In vivo depletion of T  ceil subsets 
was achieved by intravenous injection of the corresponding mAb 
at the dose of 200/,g/mouse, three times per week, starting 1 wk 
before any other manipulation. The success ofT cell subset deple- 
tion was ascertained by indirect immunofluorescence microscopy, 
using  the same  mAb applied  for in vivo treatment and FITC- 
conjugated mouse anti-rat Ig antibodies (Becton Dickinson & Co., 
Mountain View, CA) with appropriate dilutions. Depletion was 
invariably  >95% after 2 wk of treatment (usually 200 spleen or 
lymph node ceils were analyzed).  Treatments were maintained for 
2 wk after grafting. 
Preparation of  Non-T Cells.  A mixture of spleen and lymph node 
cells were freed from red blood cells by a brief incubation in 0.84% 
ammonium chloride, and the remaining viable cells (10Vml) were 
then incubated with appropriate dilution of a cocktail of anti-L3T4, 
anti-Lyt-2, and anti-Thyl.2 mAbs at 4~  for 45 min. Cells were 
washed in BSS and incubated at 37~  for 45 rain with baby rabbit 
complement at a final dilution of 1:10. Such a treatment completely 
abrogated the capacity of these cells to proliferate to Con A in vitro. 
Preparation ofT Cells and T Cell Subsets.  T cells were obtained 
from spleens and lymph nodes. Ceils were passed over a Sephadex 
G10 column in order to remove macrophages. The effluent cells 
were then passed over a nylon wool column, and 20--40% of the 
load cell number were eluted after a 1-h incubation at 37~  The 
nonadherent ceils were panned on plastic petri dishes coated with 
purified anti-mouse Fab antibody. T  cells were obtained by 1 h 
of incubation at 4~  T cells subsets were obtained by treatment 
of total T cells either with anti-CD4 or anti-CD8 mAbs and rabbit 
complement at the appropriated dilutions as described above. Dead 
cells were further removed by passage over Ficoll gradient. Usually 
this procedure gave >95% of purity yields as judge by indirect im- 
munofluorescence microscopy,  as described above. 
In Vitro Cell Culturing.  The responding total T cells, CD4 and 
CD8 subsets, or non T lymphocytes were prepared as above and 
resuspended in complete medium (RPM11640 supplemented with 
10%  FCS,  5  x  10 -s  M  2-ME,  sodium  pyruvate,  glutamine, 
nonessential amino acids, and 5 mM hepes buffer) at a concentra- 
tion of 2  x  10  s per culture well together with 2  ￿  10  s irradi- 
ated (3,000 rad) spleen filler cells with or without different con- 
centrations of  heart antigens in a total volume of  0.2 ml. Each culture 
was performed in triplicate in flat-bottomed microculture plates 
and maintained in a humidified atmosphere at 5% COz at 37~ 
The cultures were harvested at 96 h  after an 8-h pulse with 20 
KBq/well of [3H]TdK.  Results were calculated from uptake of 
[3H]TdK and expressed as the mean uptake in cpm of three inde- 
pendent experiments. Myocardium antigens were prepared as de- 
scribed  previously (11). 
Histological Examination.  The ears containing the heart grafts 
were fixed in Bouin's solution. After fixation, all ears were sec- 
tioned transversally  across the graft at 2-mm intervals,  embedded 
in  paraffin,  sectioned,  stained  with  hematoxylin and  eosin  or 
Masson's trichrome, and examined under the light microscope. For 
electron microscopic study, small blocks of tissue  were fixed in 
glutaraldehyde,  postfixed in osmium tetroxide, dehydrated in ace- 
tone, and embedded in araldite. Semithin sections stained with to- 
lnidine blue were examined under the light microscope, and a suit- 
able area was sdected for preparation of ultrathin sections, which 
were double stained with uranyl acetate and lead citrate, and exam- 
ined in an electron microscope at 80 kV (EM 109; Carl Zeiss, Ober- 
kocben, Germany). 
To visualize permeability alteration of the myocyte sarcolemma, 
small pieces of myocardium were immersed in a 1.2% glutaralde- 
hyde (0.3% ruthenium red mixture in 0.1 M  cacodyhte buffer, 
postfixed in a 2% osmium tetroxide) 0.3% ruthenium red mix- 
ture in 0.1 M cacodyhte buffer, dehydrated, and embedded in Epon 
(12-14). Unstained uhrathin sections selected on the basis of a light 
microscope were examined in the electron microscope. Since this 
technique is subjected to artifacts because ruthenium red is intro- 
duced during the process of immersion fixation with glutaralde- 
hyde, random sampling and blind evaluation  were performed as 
a control for these effects. 
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S2mgeneic Heart Graft Rejection in Chronically Infected Mice 
Newborn hearts grafted in syngeneic recipients showed grossly 
visible contractile activity, usually within 2 wk after surgical 
procedure. The heterotopic hearts persisted up to 100 d. On 
the contrary, grafting of syngeneic newborn hearts in mice 
already developing chronic Chagas' disease was consistently 
rejected and completely absorbed  at most by the 20th day 
posttransplantation. Actually, 70% of the grafts were acutely 
rejected and disappeared in 2 wk.  Similar results were ob- 
tained regardless of which T  cruzi strain (Y or Colombian) 
was used to generate chronic infection. Rejection of allogeneic 
hearts by normal recipients was delayed in relation to infected 
groups (Fig. 1). Furthermore, it should be pointed out that 
heart  contractile activity was never detected in the organs 
grafted into chronically infected animals. Syngeneic grafts were 
not rejected in either normal or PF strain-hyperimmunized 
mice (Fig.  1).  In fact, these grafts persist  for long periods 
(up  to  6  mo)  without  significant changes. 
Morphological Findings.  Newborn mouse syngeneic hearts 
transplanted into the ear of normal recipients became vas- 
cularized from the auricular artery at the base of the ear. The 
central cavities of the grafts were filled with adipose tissue 
(fatty infiltration). Elongated myocardial cells with abundant 
myofilaments were seen. In most of the areas, myocytes were 
arranged in parallel bundles. The nuclei were elongated. No 
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Figure 1.  Engraftment  or rejection of syngeneic  newborn hearts in 
different groups of mice. Normal BALB/c  mice (Fq), PF strain-hyper- 
immunized  BALB/c  mice (￿9  or BALB/c  mice  chronically  infected  with 
the Colombian strain of T. cruzi (0) were grafted with syngeneic  new- 
born hearts in both ears. A group of normal BALB/c  mice was grafted 
with C57BL/6 newborn  hearts as an allogeneic  control (O). Groups  were 
of 10 animals each. 
mitotic figures were seen. The interstitial space was diffusely 
widened, particularly around vessels,  due to collagen fibrils, 
fibroblasts,  and areas of mononudear cells  (Fig.  2).  These 
hearts showed a mature ultrastructural appearance with par- 
Figure 2.  Newborn myocardium  2 mo after transplantation  into the ear of syngeneic  control mice. In most of the areas, the myocytes  are arranged 
in parallel bundles. The nudei are elongated. No mitotic figures are seen. The interstitial space is diffusely  widened due to mild interstitial fibrosis. 
Fatty infiltration  (arrows)  is noted at the ventricular  cavity  and the periphery  of  the graft, s, skin; c, ear cartilage.  Hematoxylln  and eosin;  A, x 170; B, x 340. 
31  Ribeiro  dos Santos et al. alld bundles of myofibrils alternating with rows of mitochon- 
dria and differentiated intercalated discs. The findings in the 
myocardium stained with ruthenium red were similar to those 
previously described (12-14). None of the cardiac cells had 
been penetrated by the tracer, and the density was confined 
to the extraceUular space, particularly the periceUular mate- 
rial and collagen bundles. 
The syngeneic heart grafted into the ear of chronically in- 
fected mice showed a marked inflammatory infiltrate com- 
posed of lymphomononuclear cells associated with multiple 
and diffuse loci of myocytolytic necrosis (Fig. 3), quite similar 
to the pattern of allogeneic heart grafts (Fig. 4). When the 
relationship between mononudear cells and cardiocytes was 
examined by electron microscope, a dose proximity between 
the two cells could be seen. The sarcolemma of the myocar- 
dial cells had a wavy outline. The basal lamina was loosely 
adherent, with a relatively low electron density and finely 
granular appearance.  The mononuclear cells  commonly  showed 
convolution of their surface in the vicinity of the myofibrils. 
Numerous cytoplasmic projections  come into close apposi- 
Figure  3.  Syngeneic  newborn 
myoeardium 13 d after implantation 
in BALB/c  mouse chronically in- 
fected with T. cruz/. Focal myocyto- 
lyric necrosis and e~temive intersti- 
tial lymphomononudear infiltrate 
and interstitial fibrosis.  Hemat~- 
ylin and eosin;  x 410. 
Figure  4.  C57BL/6  newborn 
my~:ardium 13 d after implantation 
in normal BALB/c mouse. Diffuse 
lymphomononudeaz infiltrate as- 
sociated with severe interstitial re- 
placement  fibrosis.  Hematoxylin 
and eosin;  x410. 
32  Autoimmunity in Experimental Chagas' Disease Figure 5.  Electron  micrograph  of 
BALB/c  newborn myocardium  14 d 
after  imphntation  in  syngeneic 
mouse  chronically infected with 
T cruz/.  The interstitial  space  is wid- 
ened by cellular  infiltration of  mac- 
rophages (mo), activated lympho- 
cytes  (ly), and collagen  fibers  in the 
vicinity of myocytes (M). Uranyl 
acetate and lead citrate; x6,100. 
tion with the myocytes (Fig. 5). The ruthenium red staining 
in syngeneic myocardium transplanted  into chronically in- 
fected mice demonstrated,  similarly to the allogeneic trans- 
planted hearts, that the cytoplasmic components of myocytes 
were labded at the site of macrophage contact, denoting al- 
teration  of the plasma  membrane  permeability  (Fig.  6). 
Figure 6.  Hectr~n  micrograph  of 
BALB/c  newborn myocardinm  16 d 
after  implantation  in  syngeneic 
mouse  chronically infected with 
T. cruzi. The cytoplasmic compo- 
nents of  a macrophage  (too)  adjacent 
to  myocytes (M)  have taken up 
ruthenium red as evidenced  by their 
density. The myofibril  at the right 
of  the figure  shows  especially  intense 
ruthenium  red  staining of myo- 
fibrils, mitochondria,  and T tubules, 
predominantly  in  the  subsar- 
colemmal zone close to the macro- 
phage, cap, capillary.  Unstained sec- 
tion;  x 7,300. 
D~'fferential  Effects of In Viuo T  Cell Subset Monoclonal Anti- 
body Depletion on the Rejection of  Syngeneic Heart Grafts.  We 
have analyzed the cell population that was necessary for the 
rejection of syngeneic heart grafts in chronically infected mice 
by depletion of CD4 + or CD8 + single-positive T  lympho- 
cytes with  mAhs.  Fig.  7  shows  that  rejection of newborn 
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Figure 7.  Engraftment of syngeneic newborn hearts in chronically in- 
fected mice receiving anti-CD4 mAb treatment. Normal BALB/c mice 
([~), BALB/c mice chronically infected with Colombian strain of T. cruzi 
receiving anti-CD8 mAb therapy (~), or BALB/c mice chronically in- 
fected with the Colombian strain of T. cmzi receiving anti-CD4 mAb therapy 
(￿9  were grafted with syngeneic newborn hearts in both ears. A group 
of normal BALB/c mice was grafted with C57BL/6 newborn hearts as 
an allogeneic control (0).  Groups were of 10 animals each. 
heart tissue grafted into chronically infected mice could be 
prevented by treating the animals with anti-CD4 mAb 2 wk 
before transplantation.  In contrast, all mice receiving anti- 
CD8 treatment rejected the heart grafts within 20 d  after 
transplantation. 
Reestablishment of Heart Tissue-specific Tolerance in Chroni- 
cally Infected T. cruzi Mice by In Vivo Treatment with Anti-CD4 
mAh  Chronically infected mice that received in vivo ad- 
ministration of anti-CD4 antibodies and heart grafts there- 
after were not able to reject these transplants even after anti- 
CD4 mAb withdrawal and reconstitution of the CD4 T cell 
compartment. To better demonstrate this phenomenon, we 
treated a group of chronic infected mice with anti-CD4 mAb 
for 2 wk as described above, and after 2 mo posttreatment, 
we grafted these mice with newborn hearts. Table 1 shows 
that normal mice had accepted the majority of syngeneic grafts 
(19/20) over a period of 100 d postengraftment and do reject 
Table  1.  In  Vivo Pretreatment with Anti-CD4  mAb 
Reestablishes Heart  Tissue Tolerance 
Incidence of graft  survival 
Experimental groups  Anti-CD4  Syngeneic  Aliogeneic* 
Normal  -  19/20 (100)  0/20 (22) 
Normal  +  20/20 (100)  0/20 (23) 
Chronically infected  -  0/20  (20)  0/20 (19) 
Chronically infected  +  18/20 (100)  0/20 (23) 
allografts in the maximum 22 d posttransplantation. Previous 
treatment with anti-CD4 mAb did not block allograft rejec- 
tion. In contrast, chronically infected mice that received anti- 
CD4 mAb accepted 90%  of syngeneic grafts (18/20) over 
a period of 100 d of observation, but are still able to reject 
full allogendc heart transplants at most 23 d  postengraft- 
ment. Histopathology of these mice have confirmed that no 
inflammatory reaction was present in the tolerant groups. 
In Situ Injection ofT Cells frora Chronically Infected or Previ- 
ously Anti-CD4-treated Mice into Heart Grafts.  Thereafter, we 
investigated the ability of T  cells and their subpopulations 
from normal, chronically ~,  or T ca~'/-hyperimmunized 
mice to damage hearts grafted in normal recipients. When 
total T cells, CD4, or CD8 T lymphocyte subsets from normal 
or T. cruzi-hyperimmune mice were injected adjacently to 
hearts that have been grafted in naive syngeneic recipients, 
no significant alteration occurred. The grafts persisted up to 
100 d, and contractile activity was present. In some groups 
the incidence of graft survival was <100%, here, the few reab- 
sorbed transphnts can be considered normal events, due to 
technical problems. In contrast, injection of total T  cells or 
CD4 +  T  lymphocytes from  chronically  infected  T. cruzi 
mice resulted in a complete destruction of the organs usually 
within 4 d after injection, and invariably 100% of the grafts 
were completely reabsorbed by 7 d postinjection. On the con- 
trary,  CD8 + T  lymphocytes from the same donor group 
were not effective in inducing graft damage. We further in- 
jected into the grafts CD4 + T ceUs from chronically infected 
mice that had been previously treated with anti-CD4 mAb 
and naturally reconstituted thereafter, in order to check if 
such a reactivity would persist. We found that no graft de- 
struction could be induced by these cells and grafts persisted 
for long periods (Table 2). Moreover, histopathology revealed 
a dramatic inflammatory reaction surrounding and within 
the grafts, when CD4 or total T  cells from chronically in- 
fected mice were injected (Fig.  8). 
In Vitro Proliferative Responses of T Lymphoqtes frora Chron- 
ically Infected T  cruzi Mice to Myocardium Antigens.  Purified 
CD4 +,  CD8 §  total T  cells,  or non-T lymphocytes from 
nontreated chronically infected mice, or chronically infected 
mice previously treated with anti-CD4 mAb and naturally 
repopulated thereafter, were cultured in the presence of syn- 
geneic heart antigens and irradiated filler cells. Fig. 9 shows 
that purified CD4 + or total T  lymphocytes from nontreated 
chronically infected mice are able to proliferate to myocardial 
antigens; also, the optimal concentration of the antigen was 
20/~g/ml  (not shown). CD8 + T  ceUs did not respond to 
any concentration of myocardial antigens as well as the popu- 
lation where T  cells were eliminated. T  cells of chronically 
infected mice 2 mo posttreatment with anti-CD4 were not 
able to proliferate to myocardial antigens. Control cells ei- 
ther from normal or T. cruzi-immunized mice did not show 
any proliferative activity to heart antigens (not  shown). 
* Hearts from newborn C57BL/6 mice were grafted in BALB/c mice 
from the different experimental groups. Numbers shown in parentheses 
represent the total time of graft observation in days. 
Di~u~ion 
The pathogenesis of chronic Chagas' heart disease remains 
incompletely understood. Different mechanisms have been 
34  Autoimmunity in Experimental Chagas' Disease Table  2.  Injection  of Different  Cell  Populations  into Heart Gratis 
Donor  groups  Cell population*  Incidence of graft  survival  Period of observation 
Normal 
Hyperimmunized 
Chronically infected 
Anti-CD4-tolerized  mice 
d 
Total T  cells  18/20  100 
CD4  20/20  100 
CD8  19/20  100 
Non-T cells  20/20  100 
Total T  cells  19/20  100 
CD4  20/20  100 
CD8  18/20  100 
Non-T cells  17/20  100 
Total T  cells  0/20  7 
CD4  0/20  7 
CD8  20/20  100 
Non-T cells  18/20  100 
Total T  cells  20/20  100 
CD4  18/20  100 
CD8  19/20  100 
Non-T cells  19/20  100 
* Purified cell populations from the different experimental groups were injected within the hearts grafted in normal recipients at a cell number of 
5  x  104 in a total volume of 10/~1. Hyperimmunized  mice were inoculated four times in intervals of 7 d with 2  x  10  ~ epimastigote forms of 
the PF strain of T. cruzi and challenged 30 d after the last inoculation with 103 trypomastigote  forms of the Y or Colombian  strains of T. cruzi. 
proposed.  The lesions could be due to continuing  parasitic 
invasion of the  heart,  local release of toxins,  or both.  The 
low levels of parasitemia and the very rare findings of tissue 
parasitic  pseudocysts  are arguments  against  the  hypothesis 
that myocardial lesions are directly corrdated with the pres- 
ence of parasites. The chronic cardiomyopathy of Chagas' dis- 
ease could be a neurogenic  form of heart disease promoted 
by destruction  of the parasympathetic ganglion cells in the 
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Figure 8.  BALB/c  newborn myo- 
cardium implanted in normal syn- 
geneic mouse 4 d after injection of 
5  x  104 purified CD4 +  T  cells 
from mice chronically  infected with 
T.  cruzi. Severe and  diffuse lym- 
phomononuclear infiltrates replace 
the myocardium.  Extensive  myocyte 
necrosis  associated  with  mild 
fibrosis. Hematoxylin  and  eosin; 
x410. 20000 
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naive  hyperimmune  chronic  tolerant 
CD4 § T cells from chronically infected BALB/c mice, toler- 
ized with anti-CD4, show unresponsiveness  to myocardial  antigens. Purified 
CD4 +,  CD8 §  total  T  cells, or  non-T cells from  naive mice,  mice 
hyperimmunized  with PF strain of T cruzi, mice chronically infected with 
the Colombian strain of T. cruzi, or mice that had been treated with anti- 
CD4 were cultured (2  x  10S/well) together  with irradiated filler cells 
(2  x  10S/well) in the presence of heart antigens from syngeneic animals 
(a previous study showed that 20 #g/ml was the optimal antigen concen- 
tration) for 4 d with [3H]thymidine added for the final 8 h. Data are ex- 
pressed as the mean of triplicate wells in cpm. Data represent one of five 
similar experiments. 
heart (15). Results of histologic studies have shown a reduc- 
tion in the number of cardiac parasympathetic neurons propor- 
tional to the pathologic changes in the heart (15). These ob- 
servations  have been challenged by investigators who have 
found neither neuronal damage in the early stage of the dis- 
ease nor a relationship between neuronal counting and the 
progression of the disease (16). Functional studies in humans 
have shown that patients may have alterations in the parasym- 
pathetic autonomic control of the heart without cardiovas- 
cular symptoms (17). In contrast, results of recent studies 
have demonstrated that myocardial damage may precede func- 
tional cardiac parasympathetic injury in patients with Chagas' 
disease (18). Recently, microvascular abnormalities have been 
postulated to play a significant  role in the pathogenesis of 
chronic Chagas' heart disease (1, 6). 
The participation of autoimmune mechanisms as the main 
cause of chagasic cardiomyopathy has been postulated (2, 19). 
An important goal is the establishment of an experimental 
model that could provide strong evidence in support of the 
hypothesis and allow a reliable readout of immune manipu- 
lations by which different sets of lymphocytes could be im- 
plicated in the generation of the disease. 
In the present work we have clearly demonstrated that mice 
chronically infected with T. cmzi were able to reject syngeneic 
heart grafts. The rejection of syngeneic hearts grafted in chron- 
ically infected adult mice was faster when compared with 
the full allogeneic situation. This was in striking contrast 
to those organs grafted into normal or T  cruzi-hyperim- 
munized syngeneic recipients,  which can persist for >6 mo. 
The histological study of heart tissue grafted into chagasic 
mice revealed a persistent and intense mononuclear inflam- 
matory infiltrate, quite similar to the pattern obtained in the 
allogeneic conditions, thus indicating that cellular  mecha- 
nisms are implicated. 
A set of experiments were done to determine the pheno- 
type of the cells involved in the phenomenon of syngeneic 
heart rejection. In vivo depletion of CD4 +, but not CD8 +, 
T cells abrogates rejection. Heart grafts were retained by chron- 
ically infected mice during the course of anti-CD4 mAb treat- 
ment.  After  2  mo  of stopping antibody  injections,  the 
CD4 + population returned to normal levels, as judged by 
indirect immunofluorescence (not shown). However, grafts 
were not rejected.  Instead they persisted  for >6 mo, indi- 
cating that the recipients became tolerant.  Thereafter,  to 
differentiate between authentic tolerance and graft adapta- 
tion due to loss of the acute inflammatory reaction just after 
transplantation, a group of chronically infected mice was 
treated with the same mAb for 2 wk, and 2 mo after with- 
drawn  of the antibody and reconstitution of the CD4 + 
compartment, heart grafts were implanted. These grafts were 
not rejected,  surviving for >6 too, clearly showing that a 
state of tolerance had been reestablished. In contrast, allogeneic 
grafts were not accepted and have been rejected in the max- 
imum of 22 d posttransplantation. Anti-CD4 mAb was suc- 
cessfully used in similar experiments dealing with induction 
of tolerance to islet allografts in the mouse, or allogeneic heart 
grafts in the rat (20,  21). 
The role of CD4 molecules in T cell activation has been 
analyzed. However, there has been much controversy in this 
regard over the part played by the CD4 glycoprotein. Re- 
cently, it has been reported that when preceded by ligation 
of CD4, signaling through TCR-od/3 results in mature T 
cell unresponsiveness in vitro, due to induction of activation- 
dependent cell death by apoptosis (22).  In contrast, it has 
been observed that in vivo treatment with anti-CD4 mediates 
proliferative donal anergy of VBll T cells during allotrans- 
plantation tolerance induction to pancreatic islets of Langer- 
hans (23). The self reactivity of CD4 + T cells from chroni- 
cally infected mice could also be shown by in vitro studies, 
where these lymphocytes proliferate in the presence of heart 
antigens plus irradiated filler cells. Non-T cell populations 
or CD8 + T lymphocytes failed to show any activity in this 
assay. Moreover,  CD4 + T  cells obtained from mice previ- 
ously treated with anti-CD4 could not reject syngeneic heart 
grafts when injected in situ, thus indicating that tolerance 
after anti-CD4 treatment correlates with the disappearance 
of myocardial  reactivities  in vitro and in vivo. Our results 
do not allow further distinction between deletion or prolifer- 
ative anergy as the basis for tolerance in this model, since 
in vitro unresponsiveness to myocardium antigens detected 
after in vivo anti-CD4 treatment could not be reverted by 
addition of IL-2-rich supernatants (not shown), and no mo- 
lecular marker can be used, so far. 
In vivo studies with CD4 + T  cells from chronically in- 
fected mice have shown that these cells are able to mediate 
syngeneic heart  graft  destruction when  injected in  situ, 
whereas CD8 + or non-T cells were not effective. The bulk 
of results establishes that autoreactivity is restricted to the 
CD4 + T cell compartment, which is clearly different from 
allogeneic skin graft rejection, that has been attributed to 
both subsets ofT lymphocytes (24, 25). This is in agreement 
with other experimental models of organ-specific autoimmune 
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duction of tissular lesions (26-28).  Importantly, this is also 
in keeping with the data showing that the majority of T 
cells infiltrating the heart in both acute and chronic phases 
of experimental T.  cruzi infection actually correspond to 
CD4 + T  cells (29).  Besides,  these cells have been reported 
to modulate antibody production (30),  macrophage activa- 
tion (31, 32), and peripheral nerve cell injury (33). One might 
still argue that the results obtained by injecting cells in situ 
was a consequence of previously in vivo activated CD4 + T 
lymphocytes, independently of their putative antiheart an- 
tigens specificity. Actually, this does not seem to be the case 
since CD4 + T  cells taken from 15-d infected mice, which 
have been described to be already activated in vivo (34),  did 
not lead to any lesion when injected within the heart grafts. 
Furthermore, using the in situ injections, we could demon- 
strate the presence of CD4 + T  lymphocytes against heart 
tissues as soon as 25-30 d after initial infection, but not ear- 
lier (not shown). In addition, in vivo treatment with anti- 
IFN-'y mAb, one of the important lymphokines released by 
activated inflammatory CD4 + T cells (35),  was not able to 
block the graft damage induced by these cells (not shown). 
It is known that expression of CD4 correlates with the 
ability of the cell to recognize antigens bound to class II mol- 
ecules (36, 37) and that CD4 binds to class II molecules coag- 
gregates with the TCR/CD3  complex and aids the activa- 
tion ofT cells. However, since there is no formal demonstration 
that myocardial cells can express dass II molecules on the 
membrane, it would be difficult to accept that the CD4 + 
T  cell could account for the final effector cytotoxic cell ac- 
tivity.  The  ruthenium  red  staining  suggests  that  the 
mononuclear cell with an activated macrophage appearance 
could be the final effector cell that destroys the cardiomyo- 
cytes. In this case, CD4 + T  cells would recognize myocar- 
dial antigens together with dass II expressed on resident tissue 
macrophages or dendritic cells, thus activating these CD4 + 
T  cells with consequent production of interleukins such as 
the early T lymphocyte activation 1 (Eta-l) protein (38). This 
could initiate an inflammatory process leading to the destruc- 
tion of heart tissue. 
One interesting question raised from these data refers to 
the triggering of those autoreactive CD4 + T lymphocytes. 
Molecular mimicry between heart and T. cruzi antigens could 
eventually be responsible for further stimulation of such a 
reactivity (39). However, T. cruzi-hyperimmunized mice were 
not able to reject syngeneic heart grafts, and CD4 + T  cells 
from these mice could not destroy the grafts when injected 
in situ or proliferate in vitro in the presence of heart antigens. 
The acute infection with massive lesions of the target organ 
would be necessary to provoke the break of tissue-specific 
tolerance. For instance, during the acute phase of the disease, 
T. cruzi antigens would decorate the myocardium cells and 
augment tissue damage induced by the immune response 
against the parasite itself (40). Furthermore, polyclonal acti- 
vation of T  and B cells is an important component during 
the acute phase of T. cruzi infection. It has been suggested 
that such an activation could play an important role in the 
development of autoimmune disease a posteriori (34).  So far, 
we favor the hypothesis that extensive tissue damage and im- 
mune dysfunction during the acute infection, rather than cross- 
reactivity between T. cruzi and self antigens, are absolutely 
necessary for the appearance of organ-specific autoimmunity 
during the chronic phase. 
In conclusion, the findings in the present study allow us 
to suggest that autoimmunity is the major mechanism im- 
plicated in the rejection of syngeneic heart tissues grafted into 
the pinna of the ear of mice chronically infected with T. cruzi. 
The similarity of the lesions to those found in humans sug- 
gests that autoimmunity is involved in the pathogenesis of 
chagasic cardiomyopathy in humans. Moreover, this could 
imply therapeutic strategies by reestablishing long-term tissue- 
specific tolerance with anti-CD4 mAb treatment, mediating 
anergy, or deleting the responder CD4 + T  cells. 
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